What's new? Log in Free sign up

Transcript search / "10-K" / Page 39

5,635 transcripts

Page 39 of 100

Earnings call transcript

annual report on Form 10-K filed with the SEC on April 1, 2024, and our other periodic filings with the SEC. During the call, we will also discuss non-GAAP

Earnings call transcript

can be found in our annual report on Form 10-K for the year ended December 31, 2023, which is on file with the SEC and available on our website. Forward

Earnings call transcript

to be different from these statements include factors the company described in our annual report on Form 10-K and our quarterly report on Form 10-Q

Earnings call transcript

release and in the company's SEC filings, including its annual report on Form 10-K for the year-ended December 31, 2023. We caution you not to place

Earnings call transcript

is contained in Akamai's filings with the SEC, including our annual report on Form 10-K, in our quarterly reports on Form 10-Q. The forward-looking statements

Earnings call transcript

and other factors that could cause our actual results to differ materially. These are discussed in greater detail in our annual report on Form 10-K

Earnings call transcript

other news releases and Crinetics SEC filings, including its annual report on Form 10-K. I would also like to specify that the content

Earnings call transcript

10-K for the year ended December 31, 2023, and the quarterly report on Form 10-Q for the quarter ended June 30, 2024, and other reports filed

Earnings call transcript

and future results of Nephros. For a discussion of these forward-looking statements, please review Nephros's SEC filings, including Forms 10-K and 10-Q

Earnings call transcript

Risk Factors in our Form 10-K as filed with the Securities and Exchange Commission and updated in our Form 10-Q subsequently filed. Cutera also

Earnings call transcript

10-K and also on other periodic reports filed with the SEC. Vaxart undertakes no obligation to update any forward-looking statements after the date

Earnings call transcript

as well as the company's most recent reports on Forms 10-K and 8-K filed with the Securities and Exchange Commission. Today's presentation contains

Earnings call transcript

. For a list and description of the risks and uncertainties associated with our business, please see our Form 10-K and 10-Q filings with the Securities

Earnings call transcript

due to a variety of factors, including the risks and uncertainties detailed in the company's most recently filed Forms 10-Q and 10-K. The company

Earnings call transcript

of this call and the documents the company filed with the SEC, including its 2023 annual report on Form 10-K and the periodic reports filed or furnished since

Earnings call transcript

, please refer to the company's SEC filings, including its reports on Forms 10-K and 10-Q. TransAct undertakes no obligation to revise or update any forward

Earnings call transcript

on Form 10-K and our quarterly reports on Form 10-Q. I'd now like to turn the call over to Chris Anzalone, president and CEO of the company. Chris? Thanks

Earnings call transcript

; pandemics; disasters, natural or otherwise; and risk of cybersecurity attacks. Please refer to our annual report on Form 10-K, quarterly reports on Form 10-Q

Earnings call transcript

, uncertainties and other factors to which they are subject, please see the periodic reports on Forms 10-K, 10-Q and 8-K that we filed with the SEC as well

Earnings call transcript

actual results to differ materially, including the risks listed in our Form 10-K for the year ended December 31, 2023, as well as in our earnings press

Prev
...
35
36
37
38
39
40
41
42
43
...
Next

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.